Osseointegration Implants Market, by Product Type (Dental Implants, Knee Implants, Hip Implants, Spinal Implants and Others), by Material Type (Titanium Implants, Zirconia Implants, Stainless Steel Implants, Ceramic Implants, and Others), by End User (Hospitals, Ambulatory Centers, Dental and Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Osseointegration is defined as a direct bone anchorage to an implant surface which can provide a basis to support a prosthesis till it becomes stronger and supports firmly. Osseointegration implants is a type of implant that contains pores in which osteoblasts and cells containing connective tissue can migrate freely. Osseointegration implants are used for various applications in the field of dental implants, bone and joint replacement procedures, and implants undertaken for providing better quality of life to the amputees. It is a widely accepted implant procedure in the health care industry at present. Some of the factors that impact attachment of the bone to the metal surface include biocompatibility of the implant material, nature of the implant, surgical technique involved, and recovery time for healing.
Market Dynamics
Key players are opting for growth strategies such as new product launch, acquisitions, partnerships, joint ventures, and agreements to increase their foothold in this market. For instance, in April 2018, Integrum SE, provides innovative systems for bone-anchored prostheses launched a new revolutionary OPRA implant system, which will be initially available only in London and would be distributed through London International Patient Services (LIPS) - an organization seeking treatment for international patients. Moreover, in December 2021, Koninklijke Philips N.V., a multinational conglomerate company acquired Vesper Medical Inc., a U.S.-based medical technology company that develops minimally-invasive peripheral vascular devices. Through this acquisition, Vesper Medical will expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook